Safety and effectiveness of eribulin in Japanese patients with soft tissue sarcoma including rare subtypes: A post-marketing observational study

Soft tissue sarcomas (STSs) are a heterogeneous group of cancers with over 100 described subtypes. While these cancers are infrequent, the prognosis is quite poor, particularly for those with stage IV metastatic disease.